Woman and Man
- | Country : -
- | organs : -
- | Specialty : -
Extract
The primary objective of Part A of the trial is to describe the distribution of plasma triglycerides in patients with Type 2 Diabetes Mellitus by degree of pancreatic exocrine insufficiency (Normal: faecal elastase-1 concentration [FEC] ≥200 μg/g; Intermediate: FEC ≥100 μg/g to <200 μg/g; and Low: FEC <100 μg/g). The primary objective of Part B of the trial is to evaluate and compare the plasma exposure of docosahexaenoic acid and eicosapentaenoic acid from EPANOVA® and OMACOR®, respectively, in patients with Type 2 Diabetes Mellitus with different levels of FEC.
Inclusion criteria
- Type 2 Diabetes